NCT06261814 2026-02-17
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Thomas Jefferson University
Phase 2 Recruiting
Clinical Trials
16 trialsNCT03960008 2024-08-28
SBRTvsTACE
Lahey Clinic
Phase 3 Terminated
NCT02182687 2024-03-05
SBRTvsTACE
Lahey Clinic
Phase 2 Completed
NCT04231929 2022-03-28
BIOPEARL-FIRST
Terumo Europe N.V.
Phase NA Withdrawn
NCT03474354 2022-01-06
DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)
University of Athens
Completed
NCT04764409 2021-02-21
PATOC
Central Clinical Hospital RZD-Medicine, Russian Federation
Unknown
NCT02470533 2021-01-27
TRENDY
Erasmus Medical Center
Phase 2 Terminated
NCT02548780 2020-01-27
LifePearl-Doxo Pharmacokinetic (PK) Study
Terumo Europe N.V.
Phase NA Completed
NCT01336985 2019-12-17
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT02149771 2018-04-19
Combination Treatment for Advanced Liver Cancer
Shanghai Zhongshan Hospital
Phase 3 Withdrawn
NCT01393093 2017-06-12
TACE-KMG
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT02301091 2016-04-14
CORTT
Sun Yat-sen University
Phase 3 Unknown
NCT02631499 2015-12-22
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Fudan University
Phase 4 Unknown
NCT01798160 2015-10-20
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).
Johannes Gutenberg University Mainz
Phase 4 Completed
NCT00482586 2015-06-08
Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
Vanderbilt University
Completed
NCT01116635 2014-03-17
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
University of British Columbia
Phase 1/2 Completed